查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1375979

神經復健設備市場規模、佔有率、趨勢分析報告：依產品、治療領域、地區、細分市場預測，2024-2030

Neurorehabilitation Devices Market Size, Share & Trends Analysis Report By Product (BCI, Wearable Devices, Neurorobotics), By Therapy Area (Stroke, Parkinson's Disease, Cerebral Palsy), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 110 Pages | 商品交期: 2-10個工作天內

價格

神經復健設備市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，預計2030年全球神經復健器材市場規模將達49.8億美元，2024年至2030年年複合成長率為13.9%。

更重視重新產品發布的研發、改善患者治療效果的創新技術和設備的生產以及醫療技術，包括腦機介面 (BCI) 和神經刺激設備等遠端醫療假體設備的製造。解決方案等正在推動產業成長。改善患者治療效果的尖端工具和技術的開拓也推動了市場的成長。不斷上漲的醫療成本創造了更多的財政資源來購買最先進的神經復健設備。

神經復健領域的研究和開發資金可以由擁有大量醫療預算的公司獲得。因此，可以開發新的和改進的神經復健工具。例如，2023年3月，一家提供智慧康復解決方案的中國公司思億智慧近日透露，宣布獲得由濤資本和成都生物城股權投資基金參與的150億美元A輪投資。公司擬利用這筆資金推動神經復健整合解決方案的研發，打造新型數位復健服務平台。醫療設備製造商、學術機構和醫療保健提供者等主要產業相關人員參與了產品開發的策略合作和夥伴關係。

研究和開發資源可以透過協作結合起來，促進更快的發明和更有效率的產品開發。虛擬實境 (VR) 和 AR 等技術正在用於神經復健。 VR 和 AR 等技術可以設計引人入勝的治療環境，讓患者參與刺激活動，支持運動和認知能力的恢復。治療師可以透過 VR 和 AR 接收即時回饋。例如，2023 年 4 月，VHA（退伍軍人健康管理局）醫療保健創新和學習辦公室與專門從事最先進治療的全球醫療保健公司 Penumbra, Inc. 宣布合作，測試、共同開發和實施基於的復健醫療解決方案

神經復健設備市場報告亮點

  • 2023年，機器人和神經技術的不斷進步導致更複雜、更有效的神經機器人設備的開發，神經機器人領域以36.0%的佔有率佔據市場主導地位。
  • 2023年，中風治療領域佔最大收益佔有率，達44.3%。家庭神經復健技術的使用正在普及。
  • 透過遠端監控和遠距復健計劃擴大提供復健服務，以幫助中風患者在家中方便地繼續康復。
  • 2023年北美佔全球市場的39.08%。由於新興企業和少數老牌公司的存在，該區域市場競爭非常激烈。
  • 這些公司努力透過產品創新、合併、收購和聯盟來獲取更高的產業佔有率。

目錄

第1章 調查方法與範圍

第2章 執行摘要

第3章 神經復健設備市場變數、趨勢、範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 普及和成長前景圖
  • 產業價值鏈分析
    • 贖回框架
  • 市場動態
    • 市場促進因素分析
    • 市場抑制因素分析
  • 神經復健設備市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析
    • 主要交易及策略聯盟分析
    • 打入市場策略

第4章 神經復健設備市場：產品估算與趨勢分析

  • 定義和範圍
  • 2023年及2030年產品市場佔有率
  • 細分儀表板
  • 全球神經復健設備市場展望（按產品）
  • 2018年至2030年市場規模、預測與趨勢分析如下

第5章 神經復健器材市場：治療領域預估及趨勢分析

  • 定義和範圍
  • 2023 年和 2030 年治療領域市場佔有率
  • 細分儀表板
  • 按治療領域分類的神經復健設備市場前景
  • 2018年至2030年市場規模、預測與趨勢分析如下

第6章 神經復健設備市場：區域估計與趨勢分析

  • 2023 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 全球區域市場概況
  • 2023年區域市場佔有率和主要企業
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 2018-2030 年市場應用、預測與趨勢分析：
  • 北美洲
    • 2018-2030 年市場估計與預測
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 印度
    • 中國
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭形勢

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司/競爭分類
    • 創新者
  • 供應商形勢
    • Bioventus
    • Ectron
    • Hocoma
    • Medtronic
    • Tyromotion Inc.
    • Abbott
    • Biometrics Ltd
    • Bionik Laboratories Corp.（BNKL）
    • BioXtreme Ltd.
    • Ekso Bionics
    • Saebo, Inc
    • Kinova inc.
    • Kinestica
Product Code: GVR-1-68038-139-9

Neurorehabilitation Devices Market Growth & Trends:

The global neurorehabilitation devices market size is anticipated to reach USD 4.98 billion by 2030, registering a CAGR of 13.9% from 2024 to 2030, according to a new report by Grand View Research, Inc.. Increasing emphasis on R&D for novel product launches, production of innovative technology & devices to enhance patient outcomes, advancements in medical technology, such as manufacturing of neuroprosthetic devices, including brain-computer interfaces (BCIs) and neurostimulation devices, and the increasing adoption of telemedicine & remote rehabilitation solutions drive the industry growth. The development of cutting-edge tools and technologies to improve patient outcomes also drives market growth. Greater financial resources are available to purchase cutting-edge neurorehabilitation equipment when healthcare costs rise.

Funds might be set aside for R&D in the neurorehabilitation sector by business players with sizable healthcare budgets. The development of novel and improved tools for neurological rehabilitation may result from this. For instance, in March 2023, SiYi Intelligence, a Chinese company that offers intelligent rehabilitation solutions, recently revealed that it had raised USD 15 billion in a Series A investment round, with participation from Tao Capital and Chengdu Bio-town Equity Investment Fund. The business intended to use the funds to advance the R&D of neurorehabilitation solution integration and create a new digital rehabilitation service platform. Major industry participants, such as manufacturers of medical devices, academic institutions, and healthcare providers are involved in the strategic collaborations and partnerships for product development.

R&D resources can be combined through collaborative efforts, promoting quicker inventions and the development of more efficient products. The technologies like virtual reality (VR) and AR are being used in neurorehabilitation. They can design therapeutic settings that are engaging, allowing patients to take part in stimulating activities that support the restoration of motor and cognitive abilities. Therapists can receive real-time feedback through VR and AR. For instance, in April 2023, the Office of Healthcare Innovation and Learning of the VHA (Veterans Health Administration) and Penumbra, Inc., a global healthcare company specializing in cutting-edge therapies, announced their collaboration to work together to test, co-develop, and implement VR-based rehabilitative healthcare solutions.

Neurorehabilitation Devices Market Report Highlights:

  • In 2023, the neurorobotics segment dominated the market with a share of 36.0% due to the ongoing advancements in robotics and neurotechnology, which led to the development of more sophisticated and effective neurorobotic devices
  • The stroke therapy area segment held the largest revenue share of 44.3% in 2023. The use of home-based neurorehabilitation techniques is becoming more popular
  • The availability of rehabilitation services is increased via remote monitoring and telerehabilitation programs that enable stroke patients to continue their recovery in the convenience of their homes
  • North America dominated the global market with a share of 39.08% in 2023. The regional market is competitive due to the presence of a few established as well as emerging players
  • These companies strive to capture higher industry shares through product innovations, mergers, acquisitions, and partnerships

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. Therapy area
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
      • 1.3.5.1. Data for primary interviews in North America
      • 1.3.5.2. Data for primary interviews in Europe
      • 1.3.5.3. Data for primary interviews in Asia Pacific
      • 1.3.5.4. Data for primary interviews in Latin America
      • 1.3.5.5. Data for Primary interviews in MEA
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
    • 1.6.2. Volume price analysis (Model 2)
      • 1.6.2.1. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Therapy area outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Neurorehabilitation Devices Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Industry Value Chain Analysis
    • 3.3.1. Reimbursement framework
  • 3.4. Market Dynamics
    • 3.4.1. Market driver analysis
      • 3.4.1.1. Increasing incidence of neurological diseases
      • 3.4.1.2. Technological advancements
      • 3.4.1.3. Increasing clinical studies for the neurorehabilitation devices product development
    • 3.4.2. Market restraint analysis
      • 3.4.2.1. High cost of devices
      • 3.4.2.2. Complex regulatory framework
  • 3.5. Neurorehabilitation Devices Market Analysis Tools
    • 3.5.1. Industry Analysis - Porter's
      • 3.5.1.1. Supplier power
      • 3.5.1.2. Buyer power
      • 3.5.1.3. Substitution threat
      • 3.5.1.4. Threat of new entrant
      • 3.5.1.5. Competitive rivalry
    • 3.5.2. PESTEL Analysis
      • 3.5.2.1. Political landscape
      • 3.5.2.2. Technological landscape
      • 3.5.2.3. Economic landscape
    • 3.5.3. Major Deals & Strategic Alliances Analysis
    • 3.5.4. Market Entry Strategies

Chapter 4. Neurorehabilitation Devices Market: Product Estimates & Trend Analysis

  • 4.1. Definitions and Scope
    • 4.1.1. Neurorobotics
    • 4.1.2. Brain-Computer Interface
    • 4.1.3. Wearable Devices
    • 4.1.4. Non-Invasive Stimulators
    • 4.1.5. Others
  • 4.2. Product Market Share, 2023 & 2030
  • 4.3. Segment Dashboard
  • 4.4. Global Neurorehabilitation Devices Market by Product Outlook
  • 4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.5.1. Neurorobotics
      • 4.5.1.1. Neurorobotics market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.2. Brain-Computer Interface
      • 4.5.2.1. Brain-computer interface market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.3. Wearable Devices
      • 4.5.3.1. Wearable devices market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.4. Non-Invasive Stimulators
      • 4.5.4.1. Non-invasive stimulators market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.5. Others
      • 4.5.5.1. Others market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Neurorehabilitation Devices Market: Therapy Area Estimates & Trend Analysis

  • 5.1. Definitions and Scope
    • 5.1.1. Stroke
    • 5.1.2. Parkinson's Disease
    • 5.1.3. Multiple Sclerosis
    • 5.1.4. Cerebral Palsy
    • 5.1.5. Others
  • 5.2. Therapy area Market Share, 2023 & 2030
  • 5.3. Segment Dashboard
  • 5.4. Neurorehabilitation Devices Market by Therapy Area Outlook
  • 5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.5.1. Stroke
      • 5.5.1.1. Stroke market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.2. Parkinson's Disease
      • 5.5.2.1. Parkinson's disease market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.3. Multiple Sclerosis
      • 5.5.3.1. Multiple sclerosis market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.4. Cerebral Palsy
      • 5.5.4.1. Cerebral palsy market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.5. Others
      • 5.5.5.1. Others market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Neurorehabilitation Devices Market: Regional Estimates & Trend Analysis

  • 6.1. Regional market share analysis, 2023 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Global Regional Market Snapshot
  • 6.4. Regional Market Share and Leading Players, 2023
    • 6.4.1. North America
    • 6.4.2. Europe
    • 6.4.3. Asia Pacific
    • 6.4.4. Latin America
    • 6.4.5. Middle East and Africa
  • 6.5. Market Application, & Forecasts and Trend Analysis, 2018 to 2030:
  • 6.6. North America
    • 6.6.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.6.2. U.S.
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Competitive Scenario
      • 6.6.2.3. Regulatory framework
      • 6.6.2.4. Reimbursement scenario
      • 6.6.2.5. U.S. market estimates and forecasts, 2018 - 2030
    • 6.6.3. Canada
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Competitive Scenario
      • 6.6.3.3. Regulatory framework
      • 6.6.3.4. Reimbursement scenario
      • 6.6.3.5. Canada market estimates and forecasts, 2018 - 2030
  • 6.7. Europe
    • 6.7.1. UK
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Competitive Scenario
      • 6.7.1.3. Regulatory framework
      • 6.7.1.4. Reimbursement scenario
      • 6.7.1.5. UK market estimates and forecasts, 2018 - 2030
    • 6.7.2. Germany
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Competitive Scenario
      • 6.7.2.3. Regulatory framework
      • 6.7.2.4. Reimbursement scenario
      • 6.7.2.5. Germany market estimates and forecasts, 2018 - 2030
    • 6.7.3. France
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Competitive Scenario
      • 6.7.3.3. Regulatory framework
      • 6.7.3.4. Reimbursement scenario
      • 6.7.3.5. France market estimates and forecasts, 2018 - 2030
    • 6.7.4. Italy
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Competitive Scenario
      • 6.7.4.3. Regulatory framework
      • 6.7.4.4. Reimbursement scenario
      • 6.7.4.5. Italy market estimates and forecasts, 2018 - 2030
    • 6.7.5. Spain
      • 6.7.5.1. Key country dynamics
      • 6.7.5.2. Competitive Scenario
      • 6.7.5.3. Regulatory framework
      • 6.7.5.4. Reimbursement scenario
      • 6.7.5.5. Spain market estimates and forecasts, 2018 - 2030
    • 6.7.6. Denmark
      • 6.7.6.1. Key country dynamics
      • 6.7.6.2. Competitive Scenario
      • 6.7.6.3. Regulatory framework
      • 6.7.6.4. Reimbursement scenario
      • 6.7.6.5. Denmark market estimates and forecasts, 2018 - 2030
    • 6.7.7. Sweden
      • 6.7.7.1. Key country dynamics
      • 6.7.7.2. Competitive Scenario
      • 6.7.7.3. Regulatory framework
      • 6.7.7.4. Reimbursement scenario
      • 6.7.7.5. Sweden market estimates and forecasts, 2018 - 2030
    • 6.7.8. Norway
      • 6.7.8.1. Key country dynamics
      • 6.7.8.2. Competitive Scenario
      • 6.7.8.3. Regulatory framework
      • 6.7.8.4. Reimbursement scenario
      • 6.7.8.5. Norway market estimates and forecasts, 2018 - 2030
  • 6.8. Asia Pacific
    • 6.8.1. Japan
      • 6.8.1.1. Key country dynamics
      • 6.8.1.2. Competitive Scenario
      • 6.8.1.3. Regulatory framework
      • 6.8.1.4. Reimbursement scenario
      • 6.8.1.5. Japan market estimates and forecasts, 2018 - 2030
    • 6.8.2. India
      • 6.8.2.1. Key country dynamics
      • 6.8.2.2. Competitive Scenario
      • 6.8.2.3. Regulatory framework
      • 6.8.2.4. Reimbursement scenario
      • 6.8.2.5. India market estimates and forecasts, 2018 - 2030
    • 6.8.3. China
      • 6.8.3.1. Key country dynamics
      • 6.8.3.2. Competitive Scenario
      • 6.8.3.3. Regulatory framework
      • 6.8.3.4. Reimbursement scenario
      • 6.8.3.5. China market estimates and forecasts, 2018 - 2030
    • 6.8.4. South Korea
      • 6.8.4.1. Key country dynamics
      • 6.8.4.2. Competitive Scenario
      • 6.8.4.3. Regulatory framework
      • 6.8.4.4. Reimbursement scenario
      • 6.8.4.5. South Korea market estimates and forecasts, 2018 - 2030
    • 6.8.5. Australia
      • 6.8.5.1. Key country dynamics
      • 6.8.5.2. Competitive Scenario
      • 6.8.5.3. Regulatory framework
      • 6.8.5.4. Reimbursement scenario
      • 6.8.5.5. Australia market estimates and forecasts, 2018 - 2030
    • 6.8.6. Thailand
      • 6.8.6.1. Key country dynamics
      • 6.8.6.2. Competitive Scenario
      • 6.8.6.3. Regulatory framework
      • 6.8.6.4. Reimbursement scenario
      • 6.8.6.5. Thailand market estimates and forecasts, 2018 - 2030
  • 6.9. Latin America
    • 6.9.1. Brazil
      • 6.9.1.1. Key country dynamics
      • 6.9.1.2. Competitive Scenario
      • 6.9.1.3. Regulatory framework
      • 6.9.1.4. Reimbursement scenario
      • 6.9.1.5. Brazil market estimates and forecasts, 2018 - 2030
    • 6.9.2. Mexico
      • 6.9.2.1. Key country dynamics
      • 6.9.2.2. Competitive Scenario
      • 6.9.2.3. Regulatory framework
      • 6.9.2.4. Reimbursement scenario
      • 6.9.2.5. Mexico market estimates and forecasts, 2018 - 2030
    • 6.9.3. Argentina
      • 6.9.3.1. Key country dynamics
      • 6.9.3.2. Competitive Scenario
      • 6.9.3.3. Regulatory framework
      • 6.9.3.4. Reimbursement scenario
      • 6.9.3.5. Argentina market estimates and forecasts, 2018 - 2030
  • 6.10. MEA
    • 6.10.1. South Africa
      • 6.10.1.1. Key country dynamics
      • 6.10.1.2. Competitive Scenario
      • 6.10.1.3. Regulatory framework
      • 6.10.1.4. Reimbursement scenario
      • 6.10.1.5. South Africa market estimates and forecasts, 2018 - 2030
    • 6.10.2. Saudi Arabia
      • 6.10.2.1. Key country dynamics
      • 6.10.2.2. Competitive Scenario
      • 6.10.2.3. Regulatory framework
      • 6.10.2.4. Reimbursement scenario
      • 6.10.2.5. Saudi Arabia market estimates and forecasts, 2018 - 2030
    • 6.10.3. UAE
      • 6.10.3.1. Key country dynamics
      • 6.10.3.2. Competitive Scenario
      • 6.10.3.3. Regulatory framework
      • 6.10.3.4. Reimbursement scenario
      • 6.10.3.5. UAE market estimates and forecasts, 2018 - 2030
    • 6.10.4. Kuwait
      • 6.10.4.1. Key country dynamics
      • 6.10.4.2. Competitive Scenario
      • 6.10.4.3. Regulatory framework
      • 6.10.4.4. Reimbursement scenario
      • 6.10.4.5. Kuwait market estimates and forecasts, 2018 - 2030

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
    • 7.2.1. Innovators
  • 7.3. Vendor Landscape
    • 7.3.1. List of key distributors and channel partners
    • 7.3.2. Key customers
    • 7.3.3. Key company market share analysis, 2023
    • 7.3.4. Bioventus
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. Product benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. Ectron
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Product benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. Hocoma
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Product benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. Medtronic
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. Product benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. Tyromotion Inc.
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Product benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. Abbott
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Product benchmarking
      • 7.3.9.4. Strategic initiatives
    • 7.3.10. Biometrics Ltd
      • 7.3.10.1. Company overview
      • 7.3.10.2. Financial performance
      • 7.3.10.3. Product benchmarking
      • 7.3.10.4. Strategic initiatives
    • 7.3.11. Bionik Laboratories Corp. (BNKL)
      • 7.3.11.1. Company overview
      • 7.3.11.2. Financial performance
      • 7.3.11.3. Product benchmarking
      • 7.3.11.4. Strategic initiatives
    • 7.3.12. BioXtreme Ltd.
      • 7.3.12.1. Company overview
      • 7.3.12.2. Financial performance
      • 7.3.12.3. Product benchmarking
      • 7.3.12.4. Strategic initiatives
    • 7.3.13. Ekso Bionics
      • 7.3.13.1. Company overview
      • 7.3.13.2. Financial performance
      • 7.3.13.3. Product benchmarking
      • 7.3.13.4. Strategic initiatives
    • 7.3.14. Saebo, Inc
      • 7.3.14.1. Company overview
      • 7.3.14.2. Financial performance
      • 7.3.14.3. Product benchmarking
      • 7.3.14.4. Strategic initiatives
    • 7.3.15. Kinova inc.
      • 7.3.15.1. Company overview
      • 7.3.15.2. Financial performance
      • 7.3.15.3. Product benchmarking
      • 7.3.15.4. Strategic initiatives
    • 7.3.16. Kinestica
      • 7.3.16.1. Company overview
      • 7.3.16.2. Financial performance
      • 7.3.16.3. Product benchmarking
      • 7.3.16.4. Strategic initiatives

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviations
  • Table 3. Global neurorehabilitation devices market, by region 2018 - 2030 (USD Million)
  • Table 4. Global neurorehabilitation devices market, by product, 2018 - 2030 (USD Million)
  • Table 5. Global neurorehabilitation devices market, by therapy area, 2018 - 2030 (USD Million)
  • Table 6. North America neurorehabilitation devices market, by country, 2018 - 2030 (USD Million)
  • Table 7. North America neurorehabilitation devices market, by product, 2018 - 2030 (USD Million)
  • Table 8. North America neurorehabilitation devices market, by therapy area, 2018 - 2030 (USD Million)
  • Table 9. U.S. neurorehabilitation devices market, by product, 2018 - 2030 (USD Million)
  • Table 10. U.S. neurorehabilitation devices market, by therapy area, 2018 - 2030 (USD Million)
  • Table 11. Canada neurorehabilitation devices market, by product, 2018 - 2030 (USD Million)
  • Table 12. Canada neurorehabilitation devices market, by therapy area, 2018 - 2030 (USD Million)
  • Table 13. Europe neurorehabilitation devices market, by country, 2018 - 2030 (USD Million)
  • Table 14. Europe neurorehabilitation devices market, by product, 2018 - 2030 (USD Million)
  • Table 15. Europe neurorehabilitation devices market, by therapy area, 2018 - 2030 (USD Million)
  • Table 16. UK neurorehabilitation devices market, by product, 2018 - 2030 (USD Million)
  • Table 17. UK neurorehabilitation devices market, by therapy area, 2018 - 2030 (USD Million)
  • Table 18. Germany neurorehabilitation devices market, by product, 2018 - 2030 (USD Million)
  • Table 19. Germany neurorehabilitation devices market, by therapy area, 2018 - 2030 (USD Million)
  • Table 20. France neurorehabilitation devices market, by product, 2018 - 2030 (USD Million)
  • Table 21. France neurorehabilitation devices market, by therapy area, 2018 - 2030 (USD Million)
  • Table 22. Italy neurorehabilitation devices market, by product, 2018 - 2030 (USD Million)
  • Table 23. Italy neurorehabilitation devices market, by therapy area, 2018 - 2030 (USD Million)
  • Table 24. Spain neurorehabilitation devices market, by product, 2018 - 2030 (USD Million)
  • Table 25. Spain neurorehabilitation devices market, by therapy area, 2018 - 2030 (USD Million)
  • Table 26. Denmark neurorehabilitation devices market, by product, 2018 - 2030 (USD Million)
  • Table 27. Denmark neurorehabilitation devices market, by therapy area, 2018 - 2030 (USD Million)
  • Table 28. Sweden neurorehabilitation devices market, by product, 2018 - 2030 (USD Million)
  • Table 29. Sweden neurorehabilitation devices market, by therapy area, 2018 - 2030 (USD Million)
  • Table 30. Norway neurorehabilitation devices market, by product, 2018 - 2030 (USD Million)
  • Table 31. Norway neurorehabilitation devices market, by therapy area, 2018 - 2030 (USD Million)
  • Table 32. Asia Pacific neurorehabilitation devices market, by country, 2018 - 2030 (USD Million)
  • Table 33. Asia Pacific neurorehabilitation devices market, by product, 2018 - 2030 (USD Million)
  • Table 34. Asia Pacific neurorehabilitation devices market, by therapy area, 2018 - 2030 (USD Million)
  • Table 35. Japan neurorehabilitation devices market, by product, 2018 - 2030 (USD Million)
  • Table 36. Japan neurorehabilitation devices market, by therapy area, 2018 - 2030 (USD Million)
  • Table 37. China neurorehabilitation devices market, by product, 2018 - 2030 (USD Million)
  • Table 38. China neurorehabilitation devices market, by therapy area, 2018 - 2030 (USD Million)
  • Table 39. India neurorehabilitation devices market, by product, 2018 - 2030 (USD Million)
  • Table 40. India neurorehabilitation devices market, by therapy area, 2018 - 2030 (USD Million)
  • Table 41. Australia neurorehabilitation devices market, by product, 2018 - 2030 (USD Million)
  • Table 42. Australia neurorehabilitation devices market, by therapy area, 2018 - 2030 (USD Million)
  • Table 43. Thailand neurorehabilitation devices market, by product, 2018 - 2030 (USD Million)
  • Table 44. Thailand neurorehabilitation devices market, by therapy area, 2018 - 2030 (USD Million)
  • Table 45. South Korea neurorehabilitation devices market, by product, 2018 - 2030 (USD Million)
  • Table 46. South Korea neurorehabilitation devices market, by therapy area, 2018 - 2030 (USD Million)
  • Table 47. Latin America neurorehabilitation devices market, by country, 2018 - 2030 (USD Million)
  • Table 48. Latin America neurorehabilitation devices market, by product, 2018 - 2030 (USD Million)
  • Table 49. Latin America neurorehabilitation devices market, by therapy area, 2018 - 2030 (USD Million)
  • Table 50. Brazil neurorehabilitation devices market, by product, 2018 - 2030 (USD Million)
  • Table 51. Brazil neurorehabilitation devices market, by therapy area, 2018 - 2030 (USD Million)
  • Table 52. Mexico neurorehabilitation devices market, by product, 2018 - 2030 (USD Million)
  • Table 53. Mexico neurorehabilitation devices market, by therapy area, 2018 - 2030 (USD Million)
  • Table 54. Argentina neurorehabilitation devices market, by product, 2018 - 2030 (USD Million)
  • Table 55. Argentina neurorehabilitation devices market, by therapy area, 2018 - 2030 (USD Million)
  • Table 56. MEA neurorehabilitation devices market, by country, 2018 - 2030 (USD Million)
  • Table 57. MEA neurorehabilitation devices market, by product, 2018 - 2030 (USD Million)
  • Table 58. MEA neurorehabilitation devices market, by therapy area, 2018 - 2030 (USD Million)
  • Table 59. South Africa neurorehabilitation devices market, by product, 2018 - 2030 (USD Million)
  • Table 60. South Africa neurorehabilitation devices market, by therapy area, 2018 - 2030 (USD Million)
  • Table 61. Saudi Arabia neurorehabilitation devices market, by product, 2018 - 2030 (USD Million)
  • Table 62. Saudi Arabia neurorehabilitation devices market, by therapy area, 2018 - 2030 (USD Million)
  • Table 63. UAE neurorehabilitation devices market, by product, 2018 - 2030 (USD Million)
  • Table 64. UAE neurorehabilitation devices market, by therapy area, 2018 - 2030 (USD Million)
  • Table 65. Kuwait neurorehabilitation devices market, by product, 2018 - 2030 (USD Million)
  • Table 66. Kuwait neurorehabilitation devices market, by therapy area, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Neurorehabilitation devices market: Market snapshot
  • Fig. 9 Neurorehabilitation devices market: Market segmentation
  • Fig. 10 Neurorehabilitation devices market Strategy framework
  • Fig. 11 Parent market outlook
  • Fig. 12 Related/ancillary market outlook
  • Fig. 13 Neurorehabilitation devices market driver impact
  • Fig. 14 Neurorehabilitation devices market restraint impact
  • Fig. 15 Neurorehabilitation devices market porter's five forces analysis
  • Fig. 16 Neurorehabilitation devices market PESTEL analysis
  • Fig. 17 Neurorehabilitation devices market segment dashboard
  • Fig. 18 Neurorehabilitation devices market: Product movement Analysis
  • Fig. 19 Neurorobotics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Brain-computer interface market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Wearable devices market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Non-invasive stimulators market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Neurorehabilitation devices market: Therapy area movement Analysis
  • Fig. 25 Stroke market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Parkinson's disease market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Multiple sclerosis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Cerebral palsy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Global Neurorehabilitation devices market: Regional movement analysis
  • Fig. 31 Global Neurorehabilitation devices market: Regional outlook and key takeaways
  • Fig. 32 Global market share, by region
  • Fig. 33 North America market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Canada market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Europe market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 UK market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Germany market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 France market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Italy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 Spain market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 Denmark market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 Sweden market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 Norway market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 45 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 Japan market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 China market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 India market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 49 Australia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 50 Thailand market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 51 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 53 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 55 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 56 Middle East and Africa. market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 57 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 58 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 59 UAE market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 60 Kuwait market estimates and forecast, 2018 - 2030 (USD Million)